@article{7f717473850446678f76fe4b958edde8,
title = "Predicting future suicidal events in adolescents using the Concise Health Risk Tracking Self-Report (CHRT-SR)",
abstract = "Background: Several self-report rating scales have been developed to assess suicidal ideation, yet most have limited utility in predicting future suicide attempts. This is particularly critical in adolescence, where suicide is the second leading cause of death. This study evaluated the Concise Health Risk Tracking Self-Report (CHRT-SR) as a prospective predictor of suicide attempts and events in high-risk adolescents enrolled in a suicide-prevention intensive outpatient program (IOP). Methods: Data were collected by retrospective chart review of adolescents treated in IOP for youth with severe suicidality. At baseline, youth completed the 14-item CHRT-SR (CHRT-SR14), which assesses suicide risk based on 3 subscales: Propensity, Impulsivity, and Suicidal Thoughts. Two outcomes were assessed: actual suicide attempts and suicidal events (suicide attempt, inpatient hospitalization, or emergency department visit) during the IOP. Results: Of the 251 adolescents who completed the baseline CHRT-SR14, 26 had a suicidal event during IOP (mean time in IOP: 5.4 ± 2.3 weeks), of whom 14 had an actual suicide attempt. Youth with any suicidal event had higher scores than those without an event on the CHRT-SR14 Total (p = .005), Propensity (p = .008), and Suicidal Thoughts (p = .001) scales at baseline. Youth who made a suicide attempt had significantly higher scores than those without an event for the Total Score, Propensity, and Suicidal Thoughts subscales. CHRT-SR14 Total Score of 28 had a sensitivity of 85.7% and specificity of 56.5% in predicting suicide attempts. A score of 22 predicted suicidal events, with a sensitivity of 80.8% and specificity of 40.9%. CHRT-SR7 Total Score of 12 predicted suicide attempts, with a sensitivity of 85.7% and specificity of 53.4%. Conclusions: The CHRT-SR14 self-report predicts suicide attempts and events with at least 80% sensitivity and acceptable specificity in adolescents at high-risk for suicide.",
keywords = "Adolescents, CHRT, Predictors, Rating scales, Suicide",
author = "Mayes, {Taryn L.} and Michael Killian and Rush, {A. John} and Emslie, {Graham J.} and Thomas Carmody and Kennard, {Betsy D.} and Jha, {Manish K.} and Jessica King and Hughes, {Jennifer L.} and Trivedi, {Madhukar H.}",
note = "Funding Information: The treatment team at Children's Health Systems of Texas, Children's Medical Center, for the exceptional care provided to youth with emotional and behavioral illness. We also are thankful to all of the children and families who participated in the SPARC program. This project was also funded in part through the Center for Depression Research and Clinical Care , The Elizabeth Jordan Harris Foundation (Trivedi MH PI) and the W W Caruth Foundation (Trivedi MH PI). To access the CHRT-SR, please contact Dr. Madhukar Trivedi at cdrc@utsouthwestern.edu . Funding Information: The authors are grateful to the following contributors:, The treatment team at Children's Health Systems of Texas, Children's Medical Center, for the exceptional care provided to youth with emotional and behavioral illness. We also are thankful to all of the children and families who participated in the SPARC program. This project was also funded in part through the Center for Depression Research and Clinical Care, The Elizabeth Jordan Harris Foundation (Trivedi MH PI) and the W W Caruth Foundation (Trivedi MH PI). To access the CHRT-SR, please contact Dr. Madhukar Trivedi at cdrc@utsouthwestern.edu. Funding Information: Dr. Rush has received consulting fees from Akili, Brain Resource Inc., Compass Inc., Curbstone Consultant LLC, Emmes Corp., Johnson and Johnson (Janssen), Liva-Nova, Mind Linc, Otsuka-US, Sunovion; speaking fees from Liva-Nova; and royalties from Guilford Press and the University of Texas Southwestern Medical Center, Dallas, TX (for the Inventory of Depressive Symptoms and its derivatives). He is also named co-inventor on two patents: U.S. Patent No. 7,795,033: Methods to Predict the Outcome of Treatment with Antidepressant Medication, Inventors: McMahon FJ, Laje G, Manji H, Rush AJ, Paddock S, Wilson AS; and U.S. Patent No. 7,906,283: Methods to Identify Patients at Risk of Developing Adverse Events During Treatment with Antidepressant Medication, Inventors: McMahon FJ, Laje G, Manji H, Rush AJ, Paddock S. Dr. Emslie has received research/grant from Duke University, Forest Research Institute, and Janssen Research & Development. Dr. Emslie is a consultant for Assurex Health Inc., Lundbeck, Neuronetics Inc., Otsuka, and Pfizer Inc. Dr. Kennard is currently serving on the Board of Trustees for the Jerry M. Lewis, M.D. Mental Health Research Foundation. Dr. Kennard receives royalties from Guilford Press, Inc. Dr. Jha has received research funding from Acadia Pharmaceuticals and Janssen Research & Development, and honoraria for CME presentations from North American Center for Continuing Medical Education and Global Medical Education. Dr. Hughes receives royalties from Guilford Press. Dr. Trivedi has received research funding from NIMH, NIDA, and Patient-Centered Outcomes Research Institute (PCORI), Cancer Prevention Research Institute of Texas (CPRIT); has served as a consultant for Allergan, Alto Neuroscience Inc, Applied Clinical Intelligence LLC, Axsome Therapeutics, Boegringer Ingelheim, Engage Health Media, GreenLight VitalSign6 Inc, Janssen, Lundbeck Research USA, Merck Sharp & Dohme Corp., Navitor Pharmaceutical Inc, Otsuka, Perception Neuroscience, Pharmerit International, SAGE Therapeutics, Signant Health; and has received editorial compensation from American Psychiatric Association (Deputy Editor for American Journal of Psychiatry), Oxford University Press; Dr. Carmody owns stock in Vertex Pharmaceuticals and CRISPR Therapeutics; Ms. Mayes and Drs. Killian , and King , have no financial relationships with commercial interests. Publisher Copyright: {\textcopyright} 2020",
year = "2020",
month = jul,
doi = "10.1016/j.jpsychires.2020.04.008",
language = "English (US)",
volume = "126",
pages = "19--25",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",
}